INTERNATIONAL PATENT: GILGAMESH PHARMACEUTICALS, INC. FILES APPLICATION FOR "METHODS OF TREATING PSYCHIATRIC DISORDERS OR PAIN USING (R)-2-(4-FLUOROPHENYL)-2-(METHYLAMINO)CYCLOHEXAN-1-ONE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF"

GENEVA, Nov. 25 -- GILGAMESH PHARMACEUTICALS, INC. (113 University Place - Suite 1019New York, New York 10003) filed a patent application (PCT/US2025/029226) for "METHODS OF TREATING PSYCHIATRIC DISORDERS OR PAIN USING (R)-2-(4-FLUOROPHENYL)-2-(METHYLAMINO)CYCLOHEXAN-1-ONE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF" on May 13, 2025. With publication no. WO/2025/240537, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KRUEGEL, Andrew Carry (c/o Gilgamesh Pharmaceuticals, Inc.113 University Place - Suite 1019New York, New ...